Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 5,965

Document Document Title
WO/2009/134110A1
Invention is related to novel compounds - 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles with general formula (I). The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because th...  
WO/2009/129939A3
Disclosed is the use of 5-amino-1,2,4-thiadiazole, the salts, metal complexes, and simple derivatives thereof according to formulas (I) and (II) as a substance for inhibiting or controlling nitrification.  
WO/2009/129939A2
Disclosed is the use of 5-amino-1,2,4-thiadiazole, the salts, metal complexes, and simple derivatives thereof according to formulas (I) and (II) as a substance for inhibiting or controlling nitrification.  
WO/2009/129267A3
Pleckstrin homology domain binding compounds, pharmaceutical compositions including such compounds, and methods for their use are described herein.  
WO/2009/123316A1
Disclosed is an sGC activator, particularly a compound which is useful for the prevention or treatment of diseases including hypertension, ischemic heart diseases, heart failure, kidney diseases, arteriosclerotic diseases, atrial fibrill...  
WO/2009/123164A1
Disclosed is a compound useful as an endothelial lipase inhibitor. Specifically disclosed is a compound represented by the formula, a pharmaceutically acceptable salt thereof, or a solvate of the compound or the pharmaceutically acceptab...  
WO/2009/119980A3
The present invention relates to novel benzophenone thiazole derivatives of chemical formula 1, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof, pharmaceutical compositions containing the ...  
WO/2009/117421A3
The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention of metabolic, cardiovascular, and metabolic diseases.  
WO/2009/108720A2
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/106817A2
There is provided a compound of formula R1-CO-X-Y-Z-R2 wherein X and Z are each optional groups independently selected from saturated or unsaturated carbon chains having a length of 1 to 3 carbons; Y is SO, S, SO2, CH=CH, CH2CH2 or O; R1...  
WO/2009/108720A3
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/105214A2
This invention provides compounds of formulas H, Ia, H, and or salts thereof, pharmaceutical compositions comprising a compound of formulas H, Ia, H and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor...  
WO/2009/105214A3
This invention provides compounds of formulas H, Ia, H, and or salts thereof, pharmaceutical compositions comprising a compound of formulas H, Ia, H and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor...  
WO/2009/101082A1
The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful ...  
WO/2009/102893A2
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/101082A9
The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful ...  
WO/2009/102893A3
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antag...  
WO/2009/095098A2
The present invention relates to the use of compounds according to general formula (I) particularly benzothiadiazoles as a protection against the effects of abiotic stress on plants.  
WO/2009/095098A3
The present invention relates to the use of compounds according to general formula (I) particularly benzothiadiazoles as a protection against the effects of abiotic stress on plants.  
WO/2009/096039A1
A compound useful as an intermediate for obtaining a thiadiazole-based acaricide having a high purity in a high yield. This intermediate is obtained, for example, by reacting a 2-(4-hydroxyphenoxy)propionic acid ester represented by the ...  
WO/2009/086277A1
Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described.  
WO/2009/083105A1
The present invention relates to thiazolyloxyphenylamidines or thiadiazolyloxyphenylamidines of the general formula (I), a process for preparing them, the use of the amidines according to the invention for the control of undesirable micr...  
WO/2009/081789A1
A compound that is useful as an agent in the prevention and treatment of circulatory system, nervous system, metabolic, reproductive system, and gastrointestinal diseases. Formula (I) is a compound represented by the following: [structur...  
WO/2009/078498A1
A novel biarylpyrazole 4-carboxamide compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor ligand, which is useful for preventing or treating obesity and obesity-related metaboli...  
WO/2009/079593A1
The present invention is directed to piperidinyl and piperazinyl derivatives of formula (I) useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compoun...  
WO/2009/075080A1
Disclosed is a fluoroalkylsulfide derivative having excellent pest control activity or a salt thereof. Also disclosed is a pest control agent characterized by containing such a fluoroalkylsulfide derivative or a salt thereof as an active...  
WO/2009/076502A1
The present invention is directed to processes for the preparation of hydroxy-substituted aryl sulfamide derivatives of the formula I or pharmaceutically acceptable salts, stereoisomers or tautomers thereof, which are monoamine reuptake ...  
WO/2009/069132A2
Compounds that are capable of inhibiting an activity of a reverse transcriptase are disclosed. Further disclosed are pharmaceutical compositions containing these compounds, and methods of inhibiting an activity of reverse transcriptase a...  
WO/2009/069132A3
Compounds that are capable of inhibiting an activity of a reverse transcriptase are disclosed. Further disclosed are pharmaceutical compositions containing these compounds, and methods of inhibiting an activity of reverse transcriptase a...  
WO/2009/067600A2
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  
WO/2009/067621A1
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  
WO/2009/067600A3
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory di...  
WO/2009/061652A1
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating ...  
WO/2009/061652A8
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating ...  
WO/2009/052288A1
The present invention relates to compounds of Formula (I), below, (wherein X, R1, R2, R3, p, E, ring A, and ring B are as defined herein). The present invention also relates to compositions (including pharmaceutically acceptable composit...  
WO/2009/049180A3
The present invention relates to compounds of formula I'' useful as inhibitors of voltage -gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods ...  
WO/2009/049180A2
The present invention relates to compounds of formula I'' useful as inhibitors of voltage -gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods ...  
WO/2009/040507A1
Compounds of formula (IA) or (IB) have antibacterial activity : wherein W is =C(H)- or =N-; R3 is a radical of formula -(Alk1)m-(Z1)p-(Alk2)n-Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1, Z...  
WO/2009/037485A1
Compounds of formula (IA) or (IB) have antibacterial activity: wherein W is =CH- or =N-; Ri and R2 are independently selected from hydrogen, fluoro and chloro, provided that Ri and R2 are not each hydrogen when W is =CH-; n is 0 or 1; X ...  
WO/2009/034396A2
Methods for overcoming multiple herbicide resistance (MHR) in plants using inhibitors of GST suppression of Formula (I), novel chemical inhibitors of Formula (Ia), compositions comprising compounds of Formula (I), and uses and methods re...  
WO/2009/034396A3
Methods for overcoming multiple herbicide resistance (MHR) in plants using inhibitors of GST suppression of Formula (I), novel chemical inhibitors of Formula (Ia), compositions comprising compounds of Formula (I), and uses and methods re...  
WO/2009/030750A1
The present invention relates to compounds of Formula (I): as well as the cosmetic and pharmaceutical compositions containing such a compound.  
WO/2009/025246A1
Disclosed are a method for producing an ammonium salt a fluorinated bis-sulfonylimide and a method for producing a lithium salt of a fluorinated bis-sulfonylimide, each by employing a practical and efficient method having a high collecti...  
WO/2009/019445A1
There is provided a compound of formula (I): wherein Y has the meaning given in the description. Such compounds are potentially useful in the treatment of disorders or conditions caused by, linked to, or contributed to by, excess adiposi...  
WO/2009/019446A1
There is provided the following compound of formula (I): which compound is of potential use in the treatment of cancer, such as breast cancer.  
WO/2009/010429A2
The invention is concerned with novel heterocyclyl compounds of formula (I), wherein A, X, Y, R3, R4, R5, R6, R7, R8, R9, R10, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts there...  
WO/2009/010429A3
The invention is concerned with novel heterocyclyl compounds of formula (I), wherein A, X, Y, R3, R4, R5, R6, R7, R8, R9, R10, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts there...  
WO/2009/011871A2
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also...  
WO/2009/011871A3
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also...  
WO/2009/012283A1
Compounds of formula I active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. Formula (I) wherein Ar is optionally substi...  

Matches 351 - 400 out of 5,965